CYCLOSPORINE AND CALCIUM-CHANNEL BLOCKERS - AN EXPLOITABLE DRUG-INTERACTION

被引：11

作者：

LEIBBRANDT, DM ^{[1
]}

DAY, RO ^{[1
]}

机构：

[1] UNIV NEW S WALES,ST VINCENTS HOSP,SCH PHYSIOL & PHARMACOL,KENSINGTON,NSW 2033,AUSTRALIA

来源：

MEDICAL JOURNAL OF AUSTRALIA | 1992年 / 157卷 / 05期

关键词：

D O I：

10.5694/j.1326-5377.1992.tb137177.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：296 / 297

页数：2

共 25 条

[1] DILTIAZEM-CYCLOSPORINE INTERACTION IN CARDIAC TRANSPLANT RECIPIENTS - IMPACT ON CYCLOSPORINE DOSE AND MEDICATION COSTS [J].

BOURGE, RC ;

KIRKLIN, JK ;

NAFTEL, DC ;

FIGG, WD ;

WHITEWILLIAMS, C ;

KETCHUM, C .

AMERICAN JOURNAL OF MEDICINE, 1991, 90 (03) :402-404

[2] PHARMACOKINETIC INTERACTION BETWEEN CYCLOSPORINE AND DILTIAZEM [J].

BROCKMOLLER, J ;

NEUMAYER, HH ;

WAGNER, K ;

WEBER, W ;

HEINEMEYER, G ;

KEWITZ, H ;

ROOTS, I .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (03) :237-242

[3] EFFECT OF CYCLOSPORINE, CYCLOSPORINE METABOLITE-17, AND OTHER CYCLOSPORINE-RELATED COMPOUNDS ON LYMPHOCYTE-T CLONES DERIVED FROM REJECTED HUMAN-KIDNEY GRAFTS [J].

CHABANNES, D ;

MOREAU, JF ;

SOULILLOU, JP .

TRANSPLANTATION, 1987, 44 (06) :813-817

[4]

COLOMBANI PM, 1989, TRANSPLANT P, V21, P840

[5] DOES NIFEDIPINE AMELIORATE CYCLOSPORINE-A NEPHROTOXICITY [J].

FEEHALLY, J ;

WALLS, J ;

MISTRY, N ;

HORSBURGH, T ;

TAYLOR, J ;

VEITCH, PS ;

BELL, PRF .

BRITISH MEDICAL JOURNAL, 1987, 295 (6593) :310-310

[6]

KAHAN BD, 1989, NEW ENGL J MED, V321, P1725

[7]

KELLY JJ, 1990, TRANSPLANT P, V22, P2127

[8]

KOHLHAW K, 1988, TRANSPLANT P, V20, P572

[9] CYCLOSPORINE METABOLISM IN HUMAN-LIVER - IDENTIFICATION OF A CYTOCHROME-P-450III GENE FAMILY AS THE MAJOR CYCLOSPORINE-METABOLIZING ENZYME EXPLAINS INTERACTIONS OF CYCLOSPORINE WITH OTHER DRUGS [J].

KRONBACH, T ;

FISCHER, V ;

MEYER, UA .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (06) :630-635

[10]

LINDHOLM A, 1987, LANCET, V1, P1262

← 1 2 3 →